Novel treatment of human pancreatic cancer using masitinib combined with standard gemcitabine chemotherapy
Ontology highlight
ABSTRACT: Masitinib is a tyrosine kinase inhibitor of c-Kit, PDGFRα and β, and to some extent Lyn of the Src kinase family. We evaluated the therapeutic potential of masitinib in vitro on human pancreatic tumour cell lines and in vivo in a mouse model of human pancreatic cancer.
ORGANISM(S): Homo sapiens
PROVIDER: GSE17987 | GEO | 2009/09/05
SECONDARY ACCESSION(S): PRJNA120021
REPOSITORIES: GEO
ACCESS DATA